世界のセルライト治療市場予測　2023-2032年

出版：Inkwood Research（インクウッドリサーチ）　出版年月：2023年3月

GLOBAL CELLULITE TREATMENT MARKET FORECAST 2023-2032
世界のセルライト治療市場予測　2023-2032年

レポート目次　　お問合せ・ご注文　　価格・納期について

KEY FINDINGS
The global cellulite treatment market is anticipated to register a CAGR of 9.44% during the forecast period 2023-2032. Some of the key drivers facilitating the market’s growth include the increasing demand for aesthetic and cosmetic procedures, rising cases of obesity, as well as the rapidly booming medical tourism industry.

MARKET INSIGHTS
Cellulite is characterized as fat collections that push against the connective tissue beneath the skin. It appears on the stomach, buttocks, and thighs. Cellulite may be caused due to accumulated toxins, poor diet, genetics, pregnancy, weight gain, and inactivity.
Obesity is one of the leading health concerns globally. Obesity leads to cellulite by virtue of heightening the volume of fat trapped within irregular-sized fat lobules. According to the Centers for Disease Control and Prevention (CDC), obesity prevalence in the United States was more than 41% in 2017. Furthermore, according to the World Health Organization (WHO), approximately 39 million children under the age of 5 were obese or overweight in the year 2020. People with obesity are more vulnerable to health issues like cardiac disorders, diabetes, high blood pressure, strokes, and other conditions. Such health problems encourage individuals to undergo treatment for obesity, thereby facilitating the global cellulite treatment market growth.

REGIONAL INSIGHTS
The global cellulite treatment market growth analysis covers a detailed assessment of North America, Europe, Asia-Pacific, and Rest of World. The Asia-Pacific is set to grow with the highest CAGR during the forecast period. The regional market’s growth is primarily ascribed to the presence of skilled professionals and high-quality healthcare facilities, in addition to the lower cost of treatments and premium healthcare services.

COMPETITIVE INSIGHTS
The degree of industrial rivalry within the global cellulite treatment market is projected to be high during the forecast period. Some of the key companies operating in the market are Johnson & Johnson, AbbVie Inc, Bausch Health Companies Inc, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Companies Mentioned
1. ABBVIE INC
2. ALMA LASERS
3. BAUSCH HEALTH COMPANIES INC
4. CANDELA CORPORATION
5. CUTERA INC
6. CYNOSURE LLC
7. ENDO INTERNATIONAL PLC
8. GALDERMA SA
9. INCELER MEDIKAL CO LTD
10. JOHNSON & JOHNSON
11. MERZ PHARMA GMBH & CO KGAA
12. NUBWAY CO LTD
13. SIENTRA INC
14. SINCLAIR PHARMA
15. ZIMMER MEDIZINSYSTEME

関連市場調査レポート

Inkwood Researchでは下記地域／国別の市場調査レポートも出版しています。各レポートの詳細についてはChosaReport.comまでお問合せください。

• アジア太平洋地域のセルライト治療市場予測　2023-2032年
  ASIA-PACIFIC CELLULITE TREATMENT MARKET FORECAST 2023-2032
• 欧州のセルライト治療市場予測　2023-2032年
  EUROPE CELLULITE TREATMENT MARKET FORECAST 2023-2032
• 北米のセルライト治療市場予測　2023-2032年
  NORTH AMERICA CELLULITE TREATMENT MARKET FORECAST 2023-2032
• インドのセルライト治療市場予測　2023-2030年
  INDIA CELLULITE TREATMENT MARKET FORECAST 2023-2030

目次

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.5. MAJOR MARKET FINDINGS
2.5.1. RISING BEAUTY CONSCIOUSNESS
2.5.2. GROWING PREFERENCE TOWARDS NON-INVASIVE PROCEDURES
2.5.3. TECHNOLOGICAL ADVANCEMENTS TO PROMOTE MARKET GROWTH
2.5.4. RAPIDLY CHANGING LIFESTYLES LEADING TO OBESITY
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. GROWING DEMAND FOR AESTHETIC AND COSMETIC PROCEDURES
3.1.2. RISING CASES OF OBESITY
3.1.3. RAPIDLY BOOMING MEDICAL TOURISM INDUSTRY
3.2. KEY RESTRAINTS
3.2.1. HIGH COST OF ADVANCED CELLULITE TREATMENT
3.2.2. SIDE EFFECTS POST-TREATMENT
3.2.3. LACK OF AWARENESS
4. KEY ANALYTICS
4.1. PARENT MARKET ANALYSIS
4.2. KEY TECHNOLOGY TRENDS
4.3. PORTER’S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. GROWTH PROSPECT MAPPING
4.5. MARKET MATURITY ANALYSIS
4.6. MARKET CONCENTRATION ANALYSIS
4.7. VALUE CHAIN ANALYSIS
4.7.1. RESEARCH AND DEVELOPMENT
4.7.2. PRODUCT DEVELOPMENT
4.7.3. MARKETING AND DISTRIBUTION
4.7.4. POST-SALES MONITORING
4.8. KEY BUYING CRITERIA
4.8.1. COST
4.8.2. BRAND REPUTATION
4.8.3. USABILITY
5. MARKET BY PROCEDURE
5.1. NON-INVASIVE
5.2. MINIMALLY INVASIVE
5.3. TOPICAL
6. MARKET BY TYPE
6.1. SOFT CELLULITE
6.2. HARD CELLULITE
6.3. EDEMATOUS CELLULITE
7. MARKET BY END-USER
7.1. HOSPITALS
7.2. CLINICS AND BEAUTY CENTERS
7.3. OTHER END-USERS
8. GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1. MARKET SIZE & ESTIMATES
8.1.2. NORTH AMERICA CELLULITE TREATMENT MARKET DRIVERS
8.1.3. NORTH AMERICA CELLULITE TREATMENT MARKET CHALLENGES
8.1.4. NORTH AMERICA CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
8.1.5. KEY PLAYERS IN NORTH AMERICA CELLULITE TREATMENT MARKET
8.1.6. COUNTRY ANALYSIS
8.1.6.1. UNITED STATES
8.1.6.1.1. UNITED STATES CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.1.6.2. CANADA
8.1.6.2.1. CANADA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.2. EUROPE
8.2.1. MARKET SIZE & ESTIMATES
8.2.2. EUROPE CELLULITE TREATMENT MARKET DRIVERS
8.2.3. EUROPE CELLULITE TREATMENT MARKET CHALLENGES
8.2.4. EUROPE CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
8.2.5. KEY PLAYERS IN EUROPE CELLULITE TREATMENT MARKET
8.2.6. COUNTRY ANALYSIS
8.2.6.1. UNITED KINGDOM
8.2.6.1.1. UNITED KINGDOM CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.2.6.2. GERMANY
8.2.6.2.1. GERMANY CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.2.6.3. FRANCE
8.2.6.3.1. FRANCE CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.2.6.4. ITALY
8.2.6.4.1. ITALY CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.2.6.5. BELGIUM
8.2.6.5.1. BELGIUM CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.2.6.6. POLAND
8.2.6.6.1. POLAND CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.2.6.7. REST OF EUROPE
8.2.6.7.1. REST OF EUROPE CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.3. ASIA-PACIFIC
8.3.1. MARKET SIZE & ESTIMATES
8.3.2. ASIA-PACIFIC CELLULITE TREATMENT MARKET DRIVERS
8.3.3. ASIA-PACIFIC CELLULITE TREATMENT MARKET CHALLENGES
8.3.4. ASIA-PACIFIC CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
8.3.5. KEY PLAYERS IN ASIA-PACIFIC CELLULITE TREATMENT MARKET
8.3.6. COUNTRY ANALYSIS
8.3.6.1. CHINA
8.3.6.1.1. CHINA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.3.6.2. JAPAN
8.3.6.2.1. JAPAN CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.3.6.3. INDIA
8.3.6.3.1. INDIA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.3.6.4. SOUTH KOREA
8.3.6.4.1. SOUTH KOREA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.3.6.5. THAILAND
8.3.6.5.1. THAILAND CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.3.6.6. INDONESIA
8.3.6.6.1. INDONESIA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.3.6.7. VIETNAM
8.3.6.7.1. VIETNAM CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.3.6.8. AUSTRALIA & NEW ZEALAND
8.3.6.8.1. AUSTRALIA & NEW ZEALAND CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.3.6.9. REST OF ASIA-PACIFIC
8.3.6.9.1. REST OF ASIA-PACIFIC CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.4. REST OF WORLD
8.4.1. MARKET SIZE & ESTIMATES
8.4.2. REST OF WORLD CELLULITE TREATMENT MARKET DRIVERS
8.4.3. REST OF WORLD CELLULITE TREATMENT MARKET CHALLENGES
8.4.4. REST OF WORLD CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
8.4.5. KEY PLAYERS IN REST OF WORLD CELLULITE TREATMENT MARKET
8.4.6. REGIONAL ANALYSIS
8.4.6.1. LATIN AMERICA
8.4.6.1.1. LATIN AMERICA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.4.6.2. MIDDLE EAST & AFRICA
8.4.6.2.1. MIDDLE EAST & AFRICA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
9. COMPETITIVE LANDSCAPE
9.1. KEY STRATEGIC DEVELOPMENTS
9.1.1. ACQUISITIONS
9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
9.1.3. PARTNERSHIPS & AGREEMENTS
9.1.4. EXPANSIONS & DIVESTITURES
9.2. COMPANY PROFILES
9.2.1. ABBVIE INC
9.2.1.1. COMPANY OVERVIEW
9.2.1.2. FINANCIAL ANALYSIS
9.2.1.3. PRODUCTS / SERVICES LIST
9.2.1.4. STRENGTHS & CHALLENGES
9.2.2. ALMA LASERS
9.2.2.1. COMPANY OVERVIEW
9.2.2.2. PRODUCTS / SERVICES LIST
9.2.3. BAUSCH HEALTH COMPANIES INC.
9.2.3.1. COMPANY OVERVIEW
9.2.3.2. FINANCIAL ANALYSIS
9.2.3.3. PRODUCTS / SERVICES LIST
9.2.3.4. STRENGTHS & CHALLENGES
9.2.4. CANDELA CORPORATION
9.2.4.1. COMPANY OVERVIEW
9.2.4.2. PRODUCTS / SERVICES LIST
9.2.4.3. STRENGTHS & CHALLENGES
9.2.5. CUTERA INC
9.2.5.1. COMPANY OVERVIEW
9.2.5.2. FINANCIAL ANALYSIS
9.2.5.3. PRODUCTS / SERVICES LIST
9.2.5.4. STRENGTHS & CHALLENGES
9.2.6. CYNOSURE LLC
9.2.6.1. COMPANY OVERVIEW
9.2.6.2. PRODUCTS / SERVICES LIST
9.2.6.3. STRENGTHS & CHALLENGES
9.2.7. ENDO INTERNATIONAL PLC
9.2.7.1. COMPANY OVERVIEW
9.2.7.2. FINANCIAL ANALYSIS
9.2.7.3. PRODUCTS / SERVICES LIST
9.2.7.4. STRENGTHS & CHALLENGES
9.2.8. GALDERMA SA
9.2.8.1. COMPANY OVERVIEW
9.2.8.2. PRODUCTS / SERVICES LIST
9.2.8.3. STRENGTHS & CHALLENGES
9.2.9. INCELER MEDIKAL CO LTD
9.2.9.1. COMPANY OVERVIEW
9.2.9.2. PRODUCTS / SERVICES LIST
9.2.9.3. STRENGTHS & CHALLENGES
9.2.10. JOHNSON & JOHNSON
9.2.10.1. COMPANY OVERVIEW
9.2.10.2. FINANCIAL ANALYSIS
9.2.10.3. PRODUCTS / SERVICES LIST
9.2.10.4. STRENGTHS & CHALLENGES
9.2.11. MERZ PHARMA GMBH & CO KGAA
9.2.11.1. COMPANY OVERVIEW
9.2.11.2. PRODUCTS / SERVICES LIST
9.2.11.3. STRENGTHS & CHALLENGES
9.2.12. NUBWAY CO LTD
9.2.12.1. COMPANY OVERVIEW
9.2.12.2. PRODUCTS / SERVICES LIST
9.2.13. SIENTRA INC
9.2.13.1. COMPANY OVERVIEW
9.2.13.2. FINANCIAL ANALYSIS
9.2.13.3. PRODUCTS / SERVICES LIST
9.2.13.4. STRENGTHS & CHALLENGES
9.2.14. SINCLAIR PHARMA
9.2.14.1. COMPANY OVERVIEW
9.2.14.2. PRODUCTS / SERVICES LIST
9.2.15. ZIMMER MEDIZINSYSTEME
9.2.15.1. COMPANY OVERVIEW
9.2.15.2. PRODUCTS / SERVICES LIST
9.2.15.3. STRENGTHS & CHALLENGES
LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – CELLULITE TREATMENT
TABLE 2: GLOBAL CELLULITE TREATMENT MARKET, BY PROCEDURE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: GLOBAL CELLULITE TREATMENT MARKET, BY PROCEDURE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 4: GLOBAL NON-INVASIVE CELLULITE TREATMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: GLOBAL NON-INVASIVE CELLULITE TREATMENT MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 6: GLOBAL MINIMALLY INVASIVE CELLULITE TREATMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: GLOBAL MINIMALLY INVASIVE CELLULITE TREATMENT MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 8: GLOBAL TOPICAL CELLULITE TREATMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: GLOBAL TOPICAL CELLULITE TREATMENT MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 10: GLOBAL CELLULITE TREATMENT MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 11: GLOBAL CELLULITE TREATMENT MARKET, BY TYPE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 12: GLOBAL SOFT CELLULITE MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 13: GLOBAL SOFT CELLULITE MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 14: GLOBAL HARD CELLULITE MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 15: GLOBAL HARD CELLULITE MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 16: GLOBAL EDEMATOUS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 17: GLOBAL EDEMATOUS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 18: GLOBAL CELLULITE TREATMENT MARKET, BY END-USER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 19: GLOBAL CELLULITE TREATMENT MARKET, BY END-USER, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 20: GLOBAL HOSPITALS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 21: GLOBAL HOSPITALS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 22: GLOBAL CLINICS AND BEAUTY CENTERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 23: GLOBAL CLINICS AND BEAUTY CENTERS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 24: GLOBAL OTHER END-USERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 25: GLOBAL OTHER END-USERS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 26: GLOBAL CELLULITE TREATMENT MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 27: GLOBAL CELLULITE TREATMENT MARKET, BY GEOGRAPHY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 28: NORTH AMERICA CELLULITE TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 29: NORTH AMERICA CELLULITE TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 30: NORTH AMERICA CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
TABLE 31: LEADING PLAYERS OPERATING IN NORTH AMERICA CELLULITE TREATMENT MARKET
TABLE 32: EUROPE CELLULITE TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 33: EUROPE CELLULITE TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 34: EUROPE CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
TABLE 35: LEADING PLAYERS OPERATING IN EUROPE CELLULITE TREATMENT MARKET
TABLE 36: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 37: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 38: ASIA-PACIFIC CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
TABLE 39: LEADING PLAYERS OPERATING IN ASIA-PACIFIC CELLULITE TREATMENT MARKET
TABLE 40: REST OF WORLD CELLULITE TREATMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 41: REST OF WORLD CELLULITE TREATMENT MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 42: REST OF WORLD CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
TABLE 43: LEADING PLAYERS OPERATING IN REST OF WORLD CELLULITE TREATMENT MARKET
TABLE 44: LIST OF ACQUISITIONS
TABLE 45: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 46: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 47: LIST OF EXPANSIONS & DIVESTITURES
LIST OF FIGURES
FIGURE 1: KEY TECHNOLOGY TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING
FIGURE 4: MARKET MATURITY ANALYSIS
FIGURE 5: MARKET CONCENTRATION ANALYSIS
FIGURE 6: VALUE CHAIN ANALYSIS
FIGURE 7: KEY BUYING CRITERIA
FIGURE 8: GLOBAL CELLULITE TREATMENT MARKET, GROWTH POTENTIAL, BY PROCEDURE, IN 2022
FIGURE 9: GLOBAL CELLULITE TREATMENT MARKET, BY NON-INVASIVE, 2023-2032 (IN $ MILLION)
FIGURE 10: GLOBAL CELLULITE TREATMENT MARKET, BY MINIMALLY INVASIVE, 2023-2032 (IN $ MILLION)
FIGURE 11: GLOBAL CELLULITE TREATMENT MARKET, BY TOPICAL, 2023-2032 (IN $ MILLION)
FIGURE 12: GLOBAL CELLULITE TREATMENT MARKET, GROWTH POTENTIAL, BY TYPE, IN 2022
FIGURE 13: GLOBAL CELLULITE TREATMENT MARKET, BY SOFT CELLULITE, 2023-2032 (IN $ MILLION)
FIGURE 14: GLOBAL CELLULITE TREATMENT MARKET, BY HARD CELLULITE, 2023-2032 (IN $ MILLION)
FIGURE 15: GLOBAL CELLULITE TREATMENT MARKET, BY EDEMATOUS CELLULITE, 2023-2032 (IN $ MILLION)
FIGURE 16: GLOBAL CELLULITE TREATMENT MARKET, GROWTH POTENTIAL, BY END-USER, IN 2022
FIGURE 17: GLOBAL CELLULITE TREATMENT MARKET, BY HOSPITALS, 2023-2032 (IN $ MILLION)
FIGURE 18: GLOBAL CELLULITE TREATMENT MARKET, BY CLINICS AND BEAUTY CENTERS, 2023-2032 (IN $ MILLION)
FIGURE 19: GLOBAL CELLULITE TREATMENT MARKET, BY OTHER END-USERS, 2023-2032 (IN $ MILLION)
FIGURE 20: NORTH AMERICA CELLULITE TREATMENT MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)
FIGURE 21: UNITED STATES CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 22: CANADA CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 23: EUROPE CELLULITE TREATMENT MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)
FIGURE 24: UNITED KINGDOM CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 25: GERMANY CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 26: FRANCE CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 27: ITALY CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 28: BELGIUM CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 29: POLAND CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 30: REST OF EUROPE CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 31: ASIA-PACIFIC CELLULITE TREATMENT MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN%)
FIGURE 32: CHINA CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 33: JAPAN CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 34: INDIA CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 35: SOUTH KOREA CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 36: THAILAND CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 37: INDONESIA CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 38: VIETNAM CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 39: AUSTRALIA & NEW ZEALAND CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 40: REST OF ASIA-PACIFIC CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 41: REST OF WORLD CELLULITE TREATMENT MARKET, REGIONAL OUTLOOK, 2022 & 2032 (IN %)
FIGURE 42: LATIN AMERICA CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 43: MIDDLE EAST & AFRICA CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 44: ABBVIE INC COMPANY PROFIT 2017 – 2021 ($ BILLION)
FIGURE 45: ABBVIE INC COMPANY REVENUE – BY GEOGRAPHY, FY 2021-22 (IN %)
FIGURE 46: ABBVIE INC COMPANY REVENUE – BY SEGMENT, 2021 (IN %)
FIGURE 47: BAUSCH HEALTH COMPANIES INC COMPANY PROFIT 2017 – 2021 ($ BILLION)
FIGURE 48: BAUSCH HEALTH COMPANIES INC COMPANY REVENUE – BY GEOGRAPHY, FY 2021-22 (IN %)
FIGURE 49: BAUSCH HEALTH COMPANIES INC COMPANY REVENUE – BY SEGMENT, 2021 (IN %)
FIGURE 50: CUTERA INC COMPANY PROFIT 2017 – 2021 ($ MILLION)
FIGURE 51: CUTERA INC COMPANY REVENUE – BY GEOGRAPHY, FY 2021-22 (IN %)
FIGURE 52: CUTERA INC COMPANY REVENUE – BY SEGMENT, 2021 (IN %)
FIGURE 53: ENDO INTERNATIONAL PLC COMPANY PROFIT 2018 – 2021 ($ MILLION)
FIGURE 54: ENDO INTERNATIONAL PLC COMPANY REVENUE – BY GEOGRAPHY, FY 2021-22 (IN %)
FIGURE 55: ENDO INTERNATIONAL PLC COMPANY REVENUE – BY SEGMENT, 2021 (IN %)
FIGURE 56: JOHNSON & JOHNSON COMPANY PROFIT 2017 – 2021 ($ BILLION)
FIGURE 57: JOHNSON & JOHNSON COMPANY REVENUE – BY GEOGRAPHY, FY 2021-22 (IN %)
FIGURE 58: JOHNSON & JOHNSON COMPANY REVENUE – BY SEGMENT, 2021 (IN %)
FIGURE 59: JOHNSON & JOHNSON COMPANY REVENUE 2017 – 2021 ($ BILLION)
FIGURE 60: SIENTRA INC COMPANY PROFIT 2017 – 2021 ($ MILLION)